JP2008539215A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008539215A5 JP2008539215A5 JP2008508290A JP2008508290A JP2008539215A5 JP 2008539215 A5 JP2008539215 A5 JP 2008539215A5 JP 2008508290 A JP2008508290 A JP 2008508290A JP 2008508290 A JP2008508290 A JP 2008508290A JP 2008539215 A5 JP2008539215 A5 JP 2008539215A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- heteroaryl
- optionally substituted
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0508471.0 | 2005-04-26 | ||
| GBGB0508471.0A GB0508471D0 (en) | 2005-04-26 | 2005-04-26 | Therapeutic agents |
| PCT/GB2006/001505 WO2006114606A1 (en) | 2005-04-26 | 2006-04-25 | Fused thiazole derivatives as kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008539215A JP2008539215A (ja) | 2008-11-13 |
| JP2008539215A5 true JP2008539215A5 (https=) | 2012-08-30 |
| JP5243953B2 JP5243953B2 (ja) | 2013-07-24 |
Family
ID=34640185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008508290A Expired - Fee Related JP5243953B2 (ja) | 2005-04-26 | 2006-04-25 | キナーゼ阻害剤としての縮合チアゾール誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7888344B2 (https=) |
| EP (1) | EP1881827B1 (https=) |
| JP (1) | JP5243953B2 (https=) |
| AT (1) | ATE526021T1 (https=) |
| AU (1) | AU2006239018B2 (https=) |
| CA (1) | CA2607426C (https=) |
| ES (1) | ES2373680T3 (https=) |
| GB (1) | GB0508471D0 (https=) |
| WO (1) | WO2006114606A1 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008001076A1 (en) * | 2006-06-26 | 2008-01-03 | Ucb Pharma S.A. | Fused thiazole derivatives as kinase inhibitors |
| GB0620059D0 (en) | 2006-10-10 | 2006-11-22 | Ucb Sa | Therapeutic agents |
| GB0620818D0 (en) * | 2006-10-19 | 2006-11-29 | Ucb Sa | Therapeutic agents |
| AU2007319786A1 (en) | 2006-11-15 | 2008-05-22 | Vertex Pharmaceuticals Incorporated | Compounds useful as protein kinase inhibitors |
| AU2008218806B2 (en) | 2007-02-20 | 2011-12-01 | Novartis Ag | Imidazoquinolines as dual lipid kinase and mTOR inhibitors |
| US7893060B2 (en) | 2007-06-12 | 2011-02-22 | F. Hoffmann-La Roche Ag | Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase |
| SI2170906T1 (sl) | 2007-06-26 | 2013-07-31 | Ucb Pharma, S.A. | Zliti derivati tiazola, kot inhibitorji kinaze |
| WO2009036768A2 (en) * | 2007-09-19 | 2009-03-26 | H. Lundbeck A/S | Diagnosing potential weight gain in a subject |
| CA2704711C (en) | 2007-09-24 | 2016-07-05 | Genentech, Inc. | Thiazolopyrimidine p13k inhibitor compounds and methods of use |
| JP5348725B2 (ja) * | 2007-10-25 | 2013-11-20 | ジェネンテック， インコーポレイテッド | チエノピリミジン化合物の製造方法 |
| WO2009071895A1 (en) * | 2007-12-04 | 2009-06-11 | Ucb Pharma S.A. | Fused thiazole and thiophene derivatives as kinase inhibitors |
| WO2009071890A1 (en) * | 2007-12-04 | 2009-06-11 | Ucb Pharma S.A. | Tricyclic kinase inhibitors |
| GB0723747D0 (en) * | 2007-12-04 | 2008-12-31 | Ucb Pharma Sa | Therapeutic agents |
| US9029411B2 (en) | 2008-01-25 | 2015-05-12 | Millennium Pharmaceuticals, Inc. | Thiophenes and uses thereof |
| WO2009120826A1 (en) * | 2008-03-27 | 2009-10-01 | Wyeth | 2-aryl- and 2-heteroarylthiazolyl compounds, methods for their preparation and use thereof |
| GB0805818D0 (en) * | 2008-03-31 | 2008-04-30 | Ucb Pharma Sa | Therapeutic agents |
| US9090601B2 (en) | 2009-01-30 | 2015-07-28 | Millennium Pharmaceuticals, Inc. | Thiazole derivatives |
| US8796314B2 (en) | 2009-01-30 | 2014-08-05 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| WO2010090716A1 (en) | 2009-01-30 | 2010-08-12 | Millennium Pharmaceuticals, Inc. | Heteroaryls and their use as pi3k inhibitors |
| WO2010135504A1 (en) * | 2009-05-20 | 2010-11-25 | Glaxosmithkline Llc | Thiazolopyrimidinone derivatives as pi3 kinase inhibitors |
| US8158625B2 (en) | 2009-05-27 | 2012-04-17 | Genentech, Inc. | Bicyclic indole-pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use |
| BRPI1009022A2 (pt) | 2009-05-27 | 2016-03-08 | Hoffmann La Roche | "composto, composição farmacêutica, processo para produzir uma composição farmacêutica, uso de um composto, método para tratamento de uma doença ou transtorno e kit" |
| WO2012021611A1 (en) | 2010-08-11 | 2012-02-16 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| TW201217365A (en) | 2010-08-11 | 2012-05-01 | Millennium Pharm Inc | Heteroaryls and uses thereof |
| US8859768B2 (en) | 2010-08-11 | 2014-10-14 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| TW201307309A (zh) * | 2010-10-13 | 2013-02-16 | Millennium Pharm Inc | 雜芳基化合物及其用途 |
| CA2828415A1 (en) | 2011-03-10 | 2012-09-13 | Lupin Limited | Substituted morpholines as modulators for the calcium sensing receptor |
| AR096151A1 (es) | 2013-05-01 | 2015-12-09 | Hoffmann La Roche | Compuestos de biheteroarilo y usos de los mismos |
| WO2017156350A1 (en) | 2016-03-09 | 2017-09-14 | K-Gen, Inc. | Methods of cancer treatment |
| CN107556199A (zh) * | 2017-09-24 | 2018-01-09 | 杨子辉 | 一种3,4‑二氯‑2‑氨基‑5‑氟联苯的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020084116A (ko) * | 2000-02-07 | 2002-11-04 | 애보트 게엠베하 운트 콤파니 카게 | 2-벤조티아졸릴 우레아 유도체 및 이의 단백질 키나제억제제로서의 용도 |
| KR100774855B1 (ko) * | 2000-04-27 | 2007-11-08 | 아스텔라스세이야쿠 가부시키가이샤 | 축합 헤테로아릴 유도체 |
| US7176214B2 (en) * | 2003-05-21 | 2007-02-13 | Bristol-Myers Squibb Company | Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
-
2005
- 2005-04-26 GB GBGB0508471.0A patent/GB0508471D0/en not_active Ceased
-
2006
- 2006-04-25 US US11/912,801 patent/US7888344B2/en active Active
- 2006-04-25 JP JP2008508290A patent/JP5243953B2/ja not_active Expired - Fee Related
- 2006-04-25 WO PCT/GB2006/001505 patent/WO2006114606A1/en not_active Ceased
- 2006-04-25 AT AT06726894T patent/ATE526021T1/de not_active IP Right Cessation
- 2006-04-25 ES ES06726894T patent/ES2373680T3/es not_active Expired - Lifetime
- 2006-04-25 EP EP06726894A patent/EP1881827B1/en not_active Expired - Lifetime
- 2006-04-25 CA CA2607426A patent/CA2607426C/en not_active Expired - Lifetime
- 2006-04-25 AU AU2006239018A patent/AU2006239018B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008539215A5 (https=) | ||
| JP2008538557A5 (https=) | ||
| JP2005053931A5 (https=) | ||
| JP2009515872A5 (https=) | ||
| JP2007523139A5 (https=) | ||
| JP2008523126A5 (https=) | ||
| JP2010504286A5 (https=) | ||
| JP2007508359A5 (https=) | ||
| JP2008510828A5 (https=) | ||
| JP2005523310A5 (https=) | ||
| WO2005037781A3 (fr) | Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
| JP2005529954A5 (https=) | ||
| JP2008044952A5 (https=) | ||
| JP2010536766A5 (https=) | ||
| JP2011037841A5 (https=) | ||
| JP2014507464A5 (https=) | ||
| JP2010504908A5 (https=) | ||
| JP2012510502A5 (https=) | ||
| WO2008006043A3 (en) | 1,3-oxazole derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents | |
| JP2006525293A5 (https=) | ||
| CA2683059A1 (en) | Atropisomer of pyrrole derivative | |
| MA32642B1 (fr) | Amides utiles en therapie | |
| JP2009504793A5 (https=) | ||
| JP2008519084A5 (https=) | ||
| JP2007519618A5 (https=) |